Sudarshan Pharma Industries (BOM:543828) Change In Receivables : ₹-422 Mil (TTM As of Mar. 2025)

Sudarshan Pharma Industries Change In Receivables Chart

Sudarshan Pharma Industries Annual Data
	Trend	Mar17	Mar18	Mar19	Mar20	Mar21	Mar22	Mar23	Mar24	Mar25
Change In Receivables		Get a 7-Day Free Trial				-335.19	-130.83	-189.02	-300.93	-422.21

Sudarshan Pharma Industries Semi-Annual Data
	Mar17	Mar18	Mar19	Mar20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24	Mar25
Change In Receivables	Get a 7-Day Free Trial								-260.73	-181.40	-119.53	-67.11	-355.10

Sudarshan Pharma Industries Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹-422 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sudarshan Pharma Industries  (BOM:543828) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Sudarshan Pharma Industries's Days Sales Outstanding for the quarter that ended in Mar. 2025 is calculated as:

2. In Ben Graham's calculation of liquidation value, Sudarshan Pharma Industries's accounts receivable are only considered to be worth 75% of book value:

Sudarshan Pharma Industries's liquidation value for the quarter that ended in Mar. 2025 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sudarshan Pharma Industries Change In Receivables Related Terms

Thank you for viewing the detailed overview of Sudarshan Pharma Industries's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Sudarshan Pharma Industries Business Description